19 February 2019
Gene therapy first to 'halt' most common cause of blindness
Our Clinical Adviser comments on the story in the BBC about the woman who had gene therapy to try to halt the progression of age-related macular degeneration (AMD).
Related further reading
Reviewing the evidence for the role of supplements in eye health, particularly cataract and age-related macular degeneration (AMD).
Pilot data from surveys examining the roles of community-based and hospital optometrists in the assessment and management of patients with suspected AMD.